Page last updated: 2024-10-28

haloperidol and Cholestasis, Intrahepatic

haloperidol has been researched along with Cholestasis, Intrahepatic in 1 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Cholestasis, Intrahepatic: Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dincsoy, HP1
Saelinger, DA1

Other Studies

1 other study available for haloperidol and Cholestasis, Intrahepatic

ArticleYear
Haloperidol-induced chronic cholestatic liver disease.
    Gastroenterology, 1982, Volume: 83, Issue:3

    Topics: Adolescent; Biopsy; Cholestasis, Intrahepatic; Chronic Disease; Drug Hypersensitivity; Haloperidol;

1982